
Acetate fraction
Broken-down acetate is used in cellular energy metabolism. The energy is not strong, but the low by-product burden creates conditions that favour cellular recovery.
06 / INTAKE · 12 WEEKS
Resistance persistence and the functional threshold, the step-by-step transition of the gut ecosystem, the organic-acid metabolic switch and the autoimmune recovery sequence. The developer's working hypotheses, drawn from some 600 observations.
In plain words
Even with the same GRBM, the speed and size of the response differ from person to person. I found the reason less in the metabolome that goes in than in whether the receiving person's gut-microbiome ecosystem can accept, amplify and redeploy its signal.
Two things decide the response. One is the persistence and strength of the rejection the gut ecosystem shows toward a new diet — resistance persistence. The other is the functional threshold at which the share of dominant microbes such as lactobacilli passes a certain level. GRBM's change happens in an ecosystem transition: after resistance is overcome, as the threshold is crossed.
So a GRBM program begins with gut-microbiome analysis before intake, to understand first what kind of responding system that person's ecosystem is. The models below are not confirmed mechanisms of treatment but hypothesis-generating material for formal clinical design.
PHASE TRANSITION MODEL
Lactobacilli are scarce and particular groups over-dominate. A strong rejection can appear, and entry can usually be judged within 2–5 days
The ecosystem lowers its resistance and moves in a new metabolic direction. Metabolic waste begins to be ionized and cleared in various forms
Not just more bacteria but a stage of metabolic stabilization. Lactate, short-chain fatty acids, bile-acid and tryptophan–indole metabolism, mucosal-barrier and immune-regulation signals are likely to work together
A zone of fast, strong response and accelerated recovery, in which recovery responses of cells throughout the body, including skin cells, are observed. Weight, appetite, pain, fatigue, sleep, exercise capacity, muscle strength, emotional regulation and return to daily life appear first as indicators of recovery
15%, 35% and 43% are not established medical normal ranges but internal research criteria at which recovery signals began to appear in GRBM observation data. They will be reset for each disease group through external validation.
MICROBIOME RECOVERY RESILIENCE INDEX
I define the change before and after GRBM intake with an observational index, the Microbiome Recovery Resilience Index (MRI). It is not about how much of a particular bacterium there is, but an integrated index of whether the gut ecosystem is shifting from an "activation state" dominated by Clostridium to a "recovery state" dominated by Vital Probiotics.
Most microbes have both a beneficial and a harmful side. When the share of lactobacilli in the small intestine rises, large-intestine microbes tend more often to express beneficial traits; in the opposite case, harmful traits. Rather than fixing bacteria as good or bad by name, function is interpreted by the dominance structure and metabolic direction of the whole ecosystem.
ORGANIC ACID SWITCH
| Clostridium-dominant metabolism | GRBM Vital Probiotics-dominant metabolism | |
|---|---|---|
| Main organic acid | Butyrate-centred | Acetate and lactate–acetate compound acids |
| Ecosystem state | Imbalance, persistent resistance | A shift toward recovery |
| Cell state | Alert activation mode | Cellular recovery mode |
| Energy | A relatively strong energy flow | A gentle, low-burden energy flow |
| Handling by-products | The neutralizing burden on major organs may rise | A flow with little burden on cellular recovery |
| Tissue response | May hinder entry into recovery mode | Recovery resilience may rise |
This model does not claim that "butyrate is always harmful". Butyrate is known as an energy source for colon epithelial cells. It is a context-dependent model: the effect can differ with the species, the site and concentration of production, the dominance structure of the ecosystem and the body's state of recovery.

Broken-down acetate is used in cellular energy metabolism. The energy is not strong, but the low by-product burden creates conditions that favour cellular recovery.

It does not act simply as an acid like ordinary lactic acid, but is interpreted as taking part in a tissue-recovery flow the developer has defined as "lactate-calcium protein metabolism". In internal dental experiments, unlike the lactic acid of ordinary acidic drinks, a strengthening response of teeth and gums was observed, to be confirmed by independent analysis.
VITAL PROBIOTICS
Before VPMI is applied, many microbial groups are mixed inside a plant; after it, the Lactobacillus group comes to dominate at 90% or more. GRBM manufacturing is a microbiome-engineering process that turns the plant's internal microbial ecosystem into a lactobacilli-centred structure.
| Ordinary probiotics | GRBM Vital Probiotics | |
|---|---|---|
| Definition | Live microbes that can confer a health benefit when taken in sufficient amounts | A GRBM-specific lactobacilli microbe–metabolome complex that has interacted with VPMI-treated plants |
| Unit of evidence | Strain, CFU, clinical trials | Consortia, plant-cell interaction, metabolome networks |
| Main evaluation | Survival, strain identification, safety, function | Lactobacillus conversion rate, lactobacilli diversity, metabolome activity, the body's recovery response |
| Working hypothesis | A particular strain acts temporarily or partially in the gut | Plant-derived metabolomes and lactobacilli reorganize the gut ecosystem |
| Validation needed | Clinical validation by strain | Validation of GRBM-specific strains, metabolomes and the body's response |
Because lactobacilli differentiate into species fairly freely through horizontal gene transfer, I see clear limits in a single-strain approach. Just as research suggests a mother's gut microbe–metabolome network can influence fetal development and immune and metabolic programming, Vital Probiotics are closer to the concept of a metabolic network that supports life activity.
A strong negative correlation was observed between the spine's biomechanical flexibility and the efficiency of clearing metabolic waste.
SPINE · EXCRETION
I use Spinal Biomechanical Stiffness, which measures and quantifies the segmental mobility and tissue resistance of the spine, as an observational index. It looks at the relationship between the efficiency of nerve-signal transmission along the spine–gut–brain axis and mechanical flexibility.
In observation, the stiffer the spine, the longer the clearance of ionized metabolites took — from about 5 days to about 22 days. So to raise the effect of a metabolic intervention such as GRBM, spinal flexibility should be secured first or managed alongside. That is why exercise, massage and meditation are recommended too. → Diet & Lifestyle
AUTOIMMUNE RECOVERY MODEL
I see autoimmune disease as a chronic immune malfunction, in which gut-ecosystem imbalance, the accumulation of ageing metabolites inside cells, deposits of waste in blood and lymph vessels, weakened cell-to-cell signalling and abnormal regulation of gene expression pile on top of immune misrecognition and metabolic abnormality at the cellular level. So the aim is not to force immunity down, but to create the physiological conditions in which cells and the immune system can leave the state of over-activation and misrecognition and work normally again.
| Layer | GRBM's direction | Meaning |
|---|---|---|
| 1. Rebuilding the gut ecosystem | Forming a Vital Probiotics-centred ecosystem | Less immune-stimulating imbalance |
| 2. Intracellular clean-out | Clearing waste, abnormal metabolites and ageing lipids | Less cellular stress |
| 3. Restoring blood and lymph vessels | Realigning circulation and metabolism | Securing clearance pathways |
| 4. External miRNA | A hypothesis of gene-expression regulation | Possible normalization of abnormal cell responses |
| 5. Clearing abnormal lipids | Removing ageing lipids and damaged metabolites | Easing an inflammatory cellular environment |
| 6. Cell communication | Restoring signals between immune and tissue cells | Easing misrecognition of self-tissue |
| 7. Cellular rest mode | Shifting from over-active to recovery metabolism | A basis for Treg re-education and immune tolerance |
As T-cell re-education begins, a temporary deep, anaemia-like fatigue can appear
Classified as a signal that the central circulatory axis is reactivating
The thymus, which makes and selects T cells, goes back to work and re-education begins in earnest
Sleep that appears as the whole body enters recovery mode
A recovery heat response in which skin temperature rises about 0.8–1.2 °C while ear temperature stays the same
The immune system shifts to a state in which it recognizes its own tissues normally again
In observed cases of severe Crohn's disease and severe psoriasis, a general metabolome response appeared for about 4–8 weeks, then the sequence above was observed in the later stage, and symptom resolution and return to daily life were reported around week 12. Among participants in the early 2018 observations, some have reported no relapse as of 2026.
Autoimmune response must be confirmed not by a single number but by an integrated index. Following the patient-focused development principle of systematically gathering patients' experiences and priorities, I designed an index that records standardized outcomes such as pain resolution, skin recovery, normalized bowel movements, deep sleep, return to daily life and staying off medication.
| Axis | Detailed indicators | Purpose |
|---|---|---|
| Microbiome reset | Share and diversity of lactobacilli | Confirming the shift to a Vital Probiotics-centred ecosystem |
| Dysbiosis burden | Dominance burden of Clostridium, Enterobacteriaceae and others | Evaluating an immune-stimulating ecosystem |
| Organic-acid switch | Butyrate-dominant vs. acetate and lactate–acetate dominant | Distinguishing activation mode from recovery mode |
| Vascular-lymphatic recovery | HRV, blood flow, lymphoedema, peripheral temperature, abdominal-aortic pulsation | Recovery of circulation and clearance pathways |
| Bone-marrow activation | CBC, reticulocytes, ferritin, B12, folate | Verifying temporary anaemia-like symptoms |
| Thymic reactivation | Thymus MRI or CT, TREC, naive T cells, CD4/CD8 | Verifying thymic reactivation |
| Treg re-education | CD4+CD25+FoxP3+ Tregs, Treg/Th17, IL-10, IL-17 | Confirming restored immune tolerance |
| Autoimmune activity | CRP, ESR, TNF-α, IL-6, disease-specific autoantibodies | Evaluating inflammatory and autoimmune activity |
| Recovery sleep and temperature | Sleep measurement, HRV, cortisol rhythm, separate core and skin temperature | Making recovery responses objective |
| Functional recovery and maintenance | Pain, fatigue, weight, exercise capacity, time off medication, relapse | Person-centred recovery and relapse-free evaluation |
| Safety | Adverse events, infection, flares, blood-pressure and cardiovascular changes | Safety management |
The models here are patterns repeated across 10 sample cases, some 600 observations and individual severe cases. But external medical validation, independent metabolome analysis, standardized clinical scales, control of concurrent treatment, diet and medication, and long-term follow-up are still lacking. So these conclusions are interpreted not as confirmed evidence of treatment effects but as hypothesis-generating material for prospective observational studies and clinical trial design by disease group. The External miRNA model, too, is a key hypothesis to be validated by analysis of GRBM-specific metabolomes, vesicles and miRNA.
Source: research by the developer (Wooyoung Nam). These are internal observational data without control groups and do not claim to diagnose, treat or prevent disease. Original data can be reviewed after an NDA.
PARTNERSHIP · INVESTMENT
After signing an NDA you can review the materials, then verify the original records and the process in person during on-site due diligence in Uljin, Gyeongsangbuk-do, Korea.